Literature DB >> 23625192

The effect of wait times on oncological outcomes from periampullary adenocarcinomas.

Spencer R McLean1, Divya Karsanji, Jennifer Wilson, Elijah Dixon, Francis R Sutherland, Janice Pasieka, Chad Ball, Oliver F Bathe.   

Abstract

BACKGROUND: Overall few patients presenting with periampullary adenocarcinomas have resectable lesions. We postulated that rapid diagnosis and treatment would enhance the likelihood of successful resection, improving survival.
METHODS: A retrospective analysis of patients undergoing surgery for resection of a pancreatic or periampullary lesion was conducted. Resection rate, disease stage and survival were evaluated as a function of wait times.
RESULTS: Pancreatic resections were booked in 355 patients. Of 193 patients with periampullary adenocarcinomas, 119 patients (61.7%) had resectable disease. There was no difference in median time from initial physician consultation to surgery in patients with resectable and unresectable disease (61 days vs. 64 days, respectively). The likelihood of successful resection was virtually identical in patients with wait times ≤ 30 and > 30 days (from surgical consultation to procedure). There was a trend toward a higher T-stage in patients who waited >30 days for surgery (P = 0.055). However, there was no difference in survival as a function of wait time.
CONCLUSIONS: This series does not demonstrate an advantage for rapid diagnosis and surgery, in terms of resection rate and survival. However, further study is required in a larger cohort of patients, to confirm these findings.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23625192     DOI: 10.1002/jso.23338

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic Cancer.

Authors:  Katelin A Mirkin; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastrointest Surg       Date:  2018-03-08       Impact factor: 3.452

2.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

3.  Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis.

Authors:  Amar B Deshwar; Elizabeth Sugar; Deirdre Torto; Ana De Jesus-Acosta; Matthew J Weiss; Christopher L Wolfgang; Dung Le; Jin He; Richard Burkhart; Lei Zheng; Daniel Laheru; Mark Yarchoan
Journal:  Ann Pancreat Cancer       Date:  2018-02-27

Review 4.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

5.  Efficacy of a dual-ring wound protector for prevention of incisional surgical site infection after Whipple's procedure (pancreaticoduodenectomy) with preoperatively-placed intrabiliary stents: protocol for a randomised controlled trial.

Authors:  Alexsander K Bressan; Derek J Roberts; Janet P Edwards; Sana U Bhatti; Elijah Dixon; Francis R Sutherland; Oliver Bathe; Chad G Ball
Journal:  BMJ Open       Date:  2014-08-21       Impact factor: 2.692

6.  Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.

Authors:  E Visser; A G Leeftink; P S N van Rossum; S Siesling; R van Hillegersberg; J P Ruurda
Journal:  Ann Surg Oncol       Date:  2016-03-24       Impact factor: 5.344

7.  Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.

Authors:  Yarrow J McConnell; Farshad Farshidfar; Aalim M Weljie; Karen A Kopciuk; Elijah Dixon; Chad G Ball; Francis R Sutherland; Hans J Vogel; Oliver F Bathe
Journal:  Metabolites       Date:  2017-01-13

8.  The survival impact of surgical waiting time in patients with resectable pancreatic head cancer.

Authors:  Hye Kyoung Seo; Dae Wook Hwang; Seo Young Park; Yejong Park; Seung Jae Lee; Jae Hoon Lee; Ki Byung Song; Young-Joo Lee; Song Cheol Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-11-27

9.  Survival Advantage of Upfront Surgery for Pancreatic Head Cancer Without Preoperative Biliary Drainage.

Authors:  Rupaly Pande; James Hodson; Ravi Marudanayagam; N Chatzizacharias; Bobby Dasari; Paolo Muiesan; Robert P Sutcliffe; Darius F Mirza; John Isaac; Keith J Roberts
Journal:  Front Oncol       Date:  2020-11-03       Impact factor: 6.244

10.  Impact of time interval between multidisciplinary team meeting and intended pancreatoduodenectomy on oncological outcomes.

Authors:  M W Steen; L B van Rijssen; S Festen; O R Busch; B Groot Koerkamp; L G van der Geest; I H de Hingh; H C van Santvoort; M G Besselink; M F Gerhards
Journal:  BJS Open       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.